Liver cancer

An anti-hypertension drug could potentially be repurposed as a more affordable treatment for liver cancer.

A new spatial genomic scoring system outdoes existing tools at identifying patients at risk of recurring liver tumours.

A comprehensive study of liver tumours reveals that a small fraction of aggressive cells can have an outsized effect on patient outcomes.

Liver tumors gain immune tolerance by activating cellular mechanisms involved in fetal development.

By interfering with the production and downstream activity of a molecule called Agrin in tumors, scientists can stop the sprouting of blood vessels that promote cancer progression.

Researchers reveal that the buildup of branched-chain amino acids fuels the growth and aggressiveness of liver cancer cells.

Molecular dissection of bile duct cancer reveals subtypes with different origins and varying potential treatments

Immune system B cells play a role in tackling liver cancer and provide a marker for patient prognosis

New research sheds light on the molecular mechanisms by which a virus contributes to cancer